Acrongenomics Inc (AGNM) SEC Filing 10-Q Quarterly report for the period ending Thursday, June 30, 2011

Acrongenomics Inc

CIK: 1104502 Ticker: AGNM
Document and Entity Information
6 Months Ended
Jun. 30, 2011
Aug. 08, 2012
Document and Entity Information    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2011  
Trading Symbol agnm  
Entity Registrant Name ACRONGENOMICS INC  
Entity Central Index Key 0001104502  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   30,205,086
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well Known Seasoned Issuer No  
Document Fiscal Year Focus 2011  
Document Fiscal Period Focus Q2  

View differences made from one quarter to another to evaluate Acrongenomics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acrongenomics Inc.


Assess how Acrongenomics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acrongenomics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: AGNM
CIK: 1104502
Form Type: 10-Q Quarterly Report
Accession Number: 0001062993-12-002695
Submitted to the SEC: Wed Aug 08 2012 2:06:36 PM EST
Accepted by the SEC: Wed Aug 08 2012
Period: Thursday, June 30, 2011
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: